Loading...
MacroGenics Inc (MGNX) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock lacks positive momentum, has weak financial performance, and shows no significant positive catalysts or trading signals. Holding off on this investment is recommended.
The MACD is negative and expanding (-0.0183), indicating bearish momentum. RSI is neutral at 39.911, and moving averages are converging, suggesting no clear trend. The stock is trading below the pivot level of 1.775, with key support at 1.674 and resistance at 1.877.

NULL identified. No recent news, no trading signals, and no significant insider or hedge fund activity.
Weak financial performance with significant YoY declines in revenue (-34.21%), net income (-70.13%), EPS (-70.00%), and gross margin (-14.46%). No recent congress trading data or influential figure activity. Technical indicators suggest bearish momentum.
In Q3 2025, the company reported a revenue decline of -34.21% YoY to $72.8M, net income dropped -70.13% YoY to $16.8M, EPS fell -70.00% YoY to $0.27, and gross margin decreased to 84.09% (-14.46% YoY).
No data on recent analyst ratings or price target changes.